Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 17824
Country/Region: Ethiopia
Year: 2016
Main Partner: Abt Associates
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $4,988,294 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $349,405
Care: TB/HIV (HVTB) $454,226
Care: Pediatric Care and Support (PDCS) $69,881
Laboratory Infrastructure (HLAB) $139,762
Health Systems Strengthening (OHSS) $613,294
Testing: HIV Testing and Counseling (HVCT) $595,238
Sexual Prevention: Other Sexual Prevention (HVOP) $285,714
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $838,571
Treatment: Adult Treatment (HTXS) $1,362,679
Treatment: Pediatric Treatment (PDTX) $279,524
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,497
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 3,708
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 155,536
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 101,508
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 264,249
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,297
HTS_TST Service Delivery Point (Facility): Other PITC 2017 134,012
HTS_TST Service Delivery Point (Facility): PMTCT 2017 24,403
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,534
HTS_TST Service Delivery Point (Facility): VCT 2017 99,818
HTS_TST Sum of Aggregated Age/Sex <15 2017 7,205
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 257,044
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 264,249
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 62
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 68
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 5,230
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 3,709
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 259
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 259
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 259
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 180
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that participate in this PT program 2017 180
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that perform this testing 2017 180
PMTCT_ART Already on ART at beginning of current pregnancy 2017 216
PMTCT_ART New on ART 2017 243
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 30,024
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 228
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 44
PMTCT_EID Sum of Infant Age disaggregates 2017 272
PMTCT_STAT By: Known positives at entry 2017 212
PMTCT_STAT By: Number of new positives identified 2017 242
PMTCT_STAT Number of new ANC and L&D clients 2017 30,939
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 30,024
PMTCT_STAT Sum of Positives Status disaggregates 2017 454
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 7
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 190
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 213
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 420
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 420
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 326
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 360
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 4,766
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,877
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 8,329
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 67
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,129
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 84
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,276
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,547
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,767
TX_CURR Aggregated Age/Sex: <15 Female 2017 312
TX_CURR Aggregated Age/Sex: <15 Male 2017 344
TX_CURR Aggregated Age/Sex: 15+ Female 2017 4,538
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,740
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,934
TX_CURR Sum of Aggregated Age/Sex <15 2017 656
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,278
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,934
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 60
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 73
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,458
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,586
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 3,177
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 3,177
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 4,766
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 4,294
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 171
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 190
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,413
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,480
TX_PVLS Numerator: Indication: Routine 2017 4,294
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 187
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 209
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,727
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,645
TX_PVLS_den Denominator: Indication: Routine 2017 4,766
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 109
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 60
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 412
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 198
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 779
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 964
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 137
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 84
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 511
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 236
Cross Cutting Budget Categories and Known Amounts Total: $479,311
Human Resources for Health $150,000
Gender: Gender Equality $150,000
Increase gender-equitable access to income and productive resources, including education
Equity in HIV prevention, care, treatment and support
Monitoring and Evaluation
Operation Research
Motor Vehicles: Purchased $179,311